JEAN GEBHARD: Open Payments
NPI 1225398688 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 19 payments from 6 companies in 2025. Trend: 2023 $129 · 2024 $35 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $177 |
| PFIZER INC. | 2 | $53 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Amgen Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, PREVNAR 20, TRELEGY ELLIPTA, INJECTAFER, OTEZLA, JARDIANCE.
Industry payments across NV — which companies pay providers there.
